Seelos Therapeutics Inc. Stock Price, News, Quote & History

Seelos Therapeutics Inc is a clinical-stage biotechnology company. The company is focused on developing products that address significant unmet needs in the Central Nervous System ("CNS") disorders and other rare disorders.

Seelos Therapeutics Inc.

Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules

Seelos Therapeutics Gets Notice of Allowance for Another US Patent for SLS-005

Seelos Therapeutics Begins Dosing in Phase 1 PK/KD Study

Seelos Therapeutics Receives IND Application Approval for SLS-005

Seelos Therapeutics Submits Investigational New Drug Application for SLS-005

Seelos Therapeutics Announces Acquisition of an Exclusive License to Intellectual Property from The UC Regents

Ligand Partner Seelos Therapeutics Becomes a Public Company

Seelos Therapeutics Announces Successful Completion of its Merger with Apricus Biosciences

5 US Longevity and Anti-aging Stocks to Watch in 2025

Top 5 Small-cap Biotech Stocks of 2025

Latest News

5m @ 13.1g/t Gold Intersected within 20m Mineralised Zone in First Drill Hole to Test New Target at Titan East

$2.48M Capital Raise to Accelerate Drilling at Mt Solitary

Quarterly Activities and Cashflow Report

Quarterly Activities Report and Appendix 5B

Starcore Closes Private Placement

Latest News

Outlook Reports world

Featured Stocks

Browse Companies